Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2021/09/10
Curator: Mmarin
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Mmarin, Victoria
Subjects
- Location of subjects
- Ireland
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Antimicrobial agent antibiotic,antibiotics,Antibiotika,Antibiotikum,antibiotique,antimicrobial,antimicrobial agents,microbicide,microbicides,Antimicrobial agent,antimicrobial agent
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Antibiotic untreated
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Antibiotic treated
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- subjects receiving antibiotics within 1 month prior to visiting an ELDERMET Clinic
- Group 0 sample size Number of subjects in the control (unexposed) group
- 143
- Group 1 sample size Number of subjects in the case (exposed) group
- 42
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Roche454
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Kruskall-Wallis
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- Matched on Factors on which subjects have been matched on in a case-control study
- age
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Source: Figure S2, Table S4
Description: Differential microbial abundance between antibiotic-treated and -untreated elderly subjects
Abundance in Group 1: decreased abundance in Antibiotic treated
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium sp. | ||
Acidaminococcus | ||
Butyrivibrio | ||
Lachnospira |
Revision editor(s): Mmarin, Claregrieve1
Signature 2
Source: Table S4
Description: Differential microbial abundance between antibiotic-treated and -untreated elderly subjects
Abundance in Group 1: increased abundance in Antibiotic treated
NCBI | Quality Control | Links |
---|---|---|
Anaerococcus | ||
Lactonifactor | ||
Lactobacillus | ||
Megasphaera | ||
Penicillium | ||
Proteus |
Revision editor(s): Mmarin, Claregrieve1
Experiment 2
Curated date: 2021/09/16
Curator: Mmarin
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Mmarin, Victoria
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Antibiotic untreated subjects in day hospital
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Antibiotic treated subjects in day hospital
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- subjects who were antibiotic-treated in a day hospital
- Group 0 sample size Number of subjects in the control (unexposed) group
- 33
- Group 1 sample size Number of subjects in the case (exposed) group
- 7
Lab analysis
Statistical Analysis
- Statistical test
- Chi-Square
- Kruskall-Wallis
- Mann-Whitney (Wilcoxon)
Signature 1
Source: Table 1
Description: comparison of microbiota between antibiotic-treated and untreated groups in day hospital facility
Abundance in Group 1: increased abundance in Antibiotic treated subjects in day hospital
NCBI | Quality Control | Links |
---|---|---|
Lactobacillus | ||
Mogibacterium | ||
Moryella | ||
Peptoniphilus | ||
Victivallis | ||
Weissella |
Revision editor(s): Mmarin, Claregrieve1
Signature 2
Source: Table 1
Description: comparison of microbiota between antibiotic-treated and untreated groups in day hospital facility
Abundance in Group 1: decreased abundance in Antibiotic treated subjects in day hospital
NCBI | Quality Control | Links |
---|---|---|
Blautia | ||
Faecalibacterium |
Revision editor(s): Mmarin, Claregrieve1
Experiment 3
Curated date: 2021/09/16
Curator: Mmarin
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Mmarin, Victoria
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Antibiotic untreated community dwelling subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Antibiotic treated community dwelling subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- community-dwelling subjects treated with antibiotics within 1 month of study
- Group 0 sample size Number of subjects in the control (unexposed) group
- 64
- Group 1 sample size Number of subjects in the case (exposed) group
- 9
Lab analysis
Statistical Analysis
Signature 1
Source: Table 1
Description: comparison of microbiota between antibiotic-treated and untreated community-dwelling subjects
Abundance in Group 1: decreased abundance in Antibiotic treated community dwelling subjects
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Pseudomonadota |
Revision editor(s): Mmarin, Claregrieve1
Signature 2
Source: Table 1
Description: comparison of microbiota between antibiotic-treated and untreated community-dwelling subjects
Abundance in Group 1: decreased abundance in Antibiotic treated community dwelling subjects
NCBI | Quality Control | Links |
---|---|---|
Bacillota | ||
Pseudomonadota |
Revision editor(s): Mmarin, Claregrieve1
Experiment 4
Curated date: 2021/09/16
Curator: Mmarin
Revision editor(s): WikiWorks, LGeistlinger, Claregrieve1, Mmarin, Victoria
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Antibiotic untreated subjects in long stay facility
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Antibiotic treated subjects in long stay facility
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- subjects in long stay facility who have had antibiotic treatment in the past month
- Group 0 sample size Number of subjects in the control (unexposed) group
- 32
- Group 1 sample size Number of subjects in the case (exposed) group
- 16
Lab analysis
Statistical Analysis
Signature 1
Source: Table 1
Description: comparison of microbiota between antibiotic-treated and untreated subjects in long stay facility
Abundance in Group 1: decreased abundance in Antibiotic treated subjects in long stay facility
NCBI | Quality Control | Links |
---|---|---|
Lachnospiraceae |
Revision editor(s): Mmarin, Claregrieve1